Table 2.
Demographic, Clinical and survival data
| RTEL1 mutation | RTEL1 WT | p values | |
|---|---|---|---|
| Gender (M/F) (% of male) | 92/59 (61) | 222/139 (61) | ns |
| Age (M ± S.D.) | 59.11 ± 16.32 | 65.5 ± 14.22 | < 0.0001 |
| Days of Hospitalization (M ± S.D.) | 22.15 ± 16.08 | 27.28 ± 34.48 | 0.048 |
| Bilateral pneumoniae (yes/no) (%yes) | 51 (34) | 137 (38) | ns |
| Oxygen Administration (yes/no) (%yes) | 104 (69) | 332 (92) | 0.0023 |
| Type of oxygen Therapy | |||
| Nasal cannula (%) | 72 (48) | 166(46) | 0.0117 |
| CPAP/High Flows (%) | 46 (31) | 148 (41) | |
| Intubation (%) | 33 (21) | 46 (13) | |
| Survival (Death) (%death) | 12 (8%) | 22 (6%) | ns |
| Number of comorbidities | ns | ||
| No comorbidities | 59 | 46 | |
| 1 | 18 | 28 | |
| 2 | 12 | 13 | |
| 3 | 10 | 9 | |
| > 4 | 1 | 4 |